Introduction {#s1}
============

Multiple signaling pathways, including insulin/IGF-1 signaling (IIS), germline signaling, mitochondrial signaling, and the signaling pathways induced by dietary restriction, regulate aging in *C. elegans* ([@bib19]; [@bib13]). The best characterized is the IIS pathway, which includes the upstream insulin/IGF-1 receptor DAF-2 and the downstream FOXO transcription factor DAF-16. Signals from DAF-2 are transmitted through AGE-1 (phosphoinositide 3-kinase) and PDK-1 (phosphoinositol-dependent kinase-1) to AKT-1, AKT-2, and SGK-1, which phosphorylate DAF-16 and prevent it from translocating to the nucleus to activate a pro-longevity gene network. Reduction-of-function mutations of the kinase genes in the IIS pathway, from *daf-2* to *akt-1*, *akt-2,* and *sgk-1*, all extend lifespan in a *daf-16*-dependent manner ([@bib20]; [@bib35]; [@bib22]; [@bib16]). Lifespan extension by reduced IIS is also observed in other species, including flies and mice, indicating that the pathway is conserved evolutionarily ([@bib19]; [@bib13]).

Compared with the kinases in the *C. elegans* IIS pathway, little is known about the protein phosphatases that neutralize the effects of the kinases. The only known example is PPTR-1, a B56 regulatory subunit of PP2A, which directs PP2A to dephosphorylate AKT-1 at T350, thereby inactivating the kinase ([@bib41]). DAF-18, the *C. elegans* PTEN, is a phosphatidylinositol 3,4,5-trisphosphate (PIP3) 3-phosphatase ([@bib39]). The phosphatase for DAF-2 has not been identified, nor the one that regulates DAF-16. Previously, *loss-of-function (lf)* mutants for *tax-6* and *cnb-1*, which encode the catalytic and regulatory subunits of *C. elegans* Calcineurin, respectively, were found to live longer than wild-type (WT) worms ([@bib8]). In mammalian systems, Calcineurin (PP2B) is a Ca^2+^/calmodulin-dependent serine/threonine protein phosphatase that has diverse functions and affects both T cell activation and heart development ([@bib7]). In *C. elegans*, Calcineurin regulates body size, thermotaxis, muscle contraction, and lifespan ([@bib2]; [@bib26]; [@bib28]; [@bib8]). The longevity phenotype of *tax-6(lf)* is partially dependent on *daf-16* ([@bib8]). More recent studies have shown that *C. elegans* Calcineurin can regulate lifespan by suppressing autophagy ([@bib9]) or inactivating CRTC-1, a co-activator of CREB ([@bib34]). However, direct targets of worm Calcineurin have not been identified.

In the current work, we addressed how worm Calcineurin TAX-6•CNB-1 regulates lifespan. We discovered that DAF-16 was phosphorylated and activated by UNC-43 at the serine 286 (S286) site. The phosphoryl group was removed by TAX-6•CNB-1. UNC-43 and TAX-6•CNB-1 therefore regulate *C. elegans* lifespan through the reversible phosphorylation of DAF-16. This regulatory mechanism has a different mode of action from the canonical IIS pathway because the phosphorylation activates, rather than represses, DAF-16. Activation of DAF-16 by UNC-43 occurs in response to different types of stress signals, such as heat, starvation, and oxidation. UNC-43 and TAX-6•CNB-1 can regulate DAF-16 independently of IIS, and the two signaling mechanisms appear to crosstalk, leading to coordinated action on DAF-16. We also show that the regulation of FOXO by CAMKII and Calcineurin is conserved in mammalian cells.

Results {#s2}
=======

TAX-6 interacts with DAF-16 in vitro and in vivo {#s2-1}
------------------------------------------------

A genetic analysis has shown that a *daf-16(null)* allele partially suppresses the longevity of the *tax-6(lf)* mutant ([@bib8]). This observation suggested that *daf-16* is either a direct or indirect downstream target of *C. elegans* Calcineurin; alternatively, it acts independently. To sort through these possibilities, we immunoprecipitated the 3xFLAG::DAF-16 protein using an anti-FLAG antibody from the lysate of MQD82, a transgenic worm strain that expresses this fusion protein and TAX-6::GFP ([Figure 1A](#fig1){ref-type="fig"}, lane 1). TAX-6::GFP from this lysate was co-precipitated with the FLAG antibody ([Figure 1A](#fig1){ref-type="fig"}, lane 4), but no TAX-6::GFP was co-precipitated from the lysate of MQD2, a strain expressing only TAX-6::GFP ([Figure 1A](#fig1){ref-type="fig"}, lanes 2 and 5). From the mixed lysates of two other transgenic strains, one expressing 3xFLAG::DAF-16 and the other expressing GFP, the GFP protein also failed to be precipitated by the FLAG antibody ([Figure 1A](#fig1){ref-type="fig"}, lanes 3 and 6). This result suggested that TAX-6 and DAF-16 interacted with each other in vivo. To determine whether the interaction was direct, we individually purified the recombinant His-tagged DAF-16 and *C. elegans* Calcineurin in the form of TAX-6•GST-CNB-1 and then mixed them together before pulling down DAF-16 with nickel beads. Indeed, TAX-6•GST-CNB-1 was pulled down successfully using His-tagged DAF-16 ([Figure 1B](#fig1){ref-type="fig"}). Further analysis suggested that the C-terminal region of DAF-16 mediates the interaction with Calcineurin ([Figure 1C](#fig1){ref-type="fig"}). Together, these results raised the interesting possibility that Calcineurin might directly regulate DAF-16 in *C. elegans*.10.7554/eLife.00518.003Figure 1.*C. elegans* Calcineurin TAX-6•CNB-1 directly binds to DAF-16 and negatively regulates DAF-16 nuclear localization.(**A**) DAF-16 and TAX-6 form a complex in vivo. Immunoprecipitation of 3xFLAG::DAF-16 expressed under the *daf-16* promoter in WT *C. elegans* pulled down TAX-6::GFP expressed under the *tax-6* promoter. The lysates were obtained from transgenic strains MQD82 (co-expressing 3xFLAG::DAF-16 and TAX-6::GFP), MQD2 (expressing TAX-6::GFP), MQD89 (expressing 3xFLAG::DAF-16), and CF1553 (expressing GFP under a *sod-3* promoter). (**B**) Calcineurin directly binds to DAF-16. Purified recombinant TAX-6•GST-CNB-1 was pulled down with Ni-NTA beads through its interaction with purified His-tagged DAF-16. (**C**) The C-terminal region of DAF-16 most likely mediates the interaction with Calcineurin. GST-DAF-16(F-C), but not GST, GST-DAF-16(N) or GST-DAF-16(N-F), pulled down TAX-6::GFP expressed in *C. elegans* (strain MQD5). The DAF-16 C-terminal region alone was not stable. Asterisk indicates full-length GST or GST fusion proteins. (**D**) DAF-16::6xHis::GFP is diffusely distributed in the WT animals but concentrated in the nucleus in *tax-6(ok2065)* animals. All GFP images shown in this paper are of L4 animals at 20°C unless otherwise indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.003](10.7554/eLife.00518.003)

TAX-6 negatively regulates DAF-16 nuclear translocation {#s2-2}
-------------------------------------------------------

In WT animals, DAF-16 is phosphorylated by AKT and diffusely distributed throughout the cell, whereas in long-lived IIS mutants, transcriptionally active DAF-16 accumulates in the nucleus ([@bib15]; [@bib32]). To determine whether DAF-16 translocates to the nucleus in long-lived Calcineurin mutants, we expressed DAF-16::6xHis::GFP using a *daf-16* promoter in the *tax-6(ok2065)* background. The functionality of this transgene was verified in *daf-2(e1370ts);daf-16(mu86)* animals; the double mutant expressing this transgene displayed the [da]{.ul}uer [f]{.ul}ormation-[c]{.ul}onstitutive (Daf-c) and longevity phenotypes of the *daf-2(e1370ts)* single mutant (not shown). DAF-16::6xHis::GFP clearly accumulated in the nuclei of different types of cells in *tax-6(ok2065)* ([Figure 1D](#fig1){ref-type="fig"}), similar to *daf-2(lf)* and *akt-1;akt-2(RNAi)* mutants ([@bib15]).

The above results strongly suggested that Calcineurin directly inhibited DAF-16, presumably by dephosphorylating it. This result is in contrast to the transmission of IIS signaling to DAF-16, during which phosphorylation of DAF-16 by AKT inhibits its nuclear accumulation. Thus, AKT and Calcineurin regulate the phosphorylation of different sites on DAF-16; otherwise, *tax-6(lf)* would have a lifespan phenotype opposite to that of *akt-1;akt-2(lf)* or *daf-2(lf)*. In contrast, they all live longer than WT worms. Therefore, Calcineurin must counteract a different kinase that activates DAF-16.

UNC-43, the *C. elegans* CAMKII homolog, promotes DAF-16 nuclear translocation and longevity {#s2-3}
--------------------------------------------------------------------------------------------

We reasoned that nuclear accumulation of DAF-16 in the *tax-6(null)* background should be dependent on a kinase that initiated the phosphorylation and nuclear translocation of DAF-16. Inactivation of this kinase should abolish the nuclear accumulation of DAF-16::GFP in *tax-6(null)* animals. We thus conducted an RNAi screen of kinase genes using the DAF-16::6xHis::GFP reporter in *tax-6(ok2065)* worms, in which the GFP signal accumulates in the nucleus ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We obtained from the Ahringer library a strong suppressor of nuclear DAF-16::GFP in an RNAi clone that targets *unc-43* ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). The suppression was confirmed by an independent, homemade *unc-43* RNAi construct ([Figure 2A](#fig2){ref-type="fig"}). The *unc-43* gene encodes the only Ca^2+^/calmodulin-dependent serine/threonine protein kinase, type II (CAMKII), in *C. elegans* ([@bib43]). UNC-43 and Calcineurin have opposing functions in locomotion and egg laying, two behavioral phenotypes that are regulated by G protein signaling ([@bib43]; [@bib2]). However, they also have non-overlapping functions because *unc-43(lf);cnb-1(null)* double mutant animals arrest at the L1 larval stage, whereas both single mutants are viable ([@bib43]; [@bib2]).10.7554/eLife.00518.004Figure 2.The effect of *tax-6(lf)* mutations on DAF-16 localization and lifespan requires *unc-43,* the CAMKII gene whose effect opposes that of *tax-6*.(**A**) *unc-43* RNAi abolished DAF-16 nuclear accumulation in *tax-6(ok2065)*. Adult stage RNAi knockdown of *tax-6* extended the WT lifespan (p=0.001) (**B**) but may have slightly shortened the lifespan of *unc-43(n498n1186)*, a putative null mutant (p=0.04) (**C**). A constitutively active gain-of-function mutation, *unc-43(n498)*, caused DAF-16::6xHis::GFP to accumulate in the nucleus (**D**) and extended lifespan in a largely *daf-16*-dependent manner (**E**). p\<0.001 for *daf-16(mu86);unc-43(gf)* vs *daf-16(mu86)* or *unc-43(gf)*. The log-rank p values are reported for all lifespan data in this study. (**F**) The *unc-43(gf);cnb-1(null)* double mutant has a longer lifespan than both the *unc-43(gf)* and *cnb-1(null)* mutants, and all three mutant strains live longer than WT animals. p\<0.001 for WT vs any mutant, and p\<0.001 for *unc-43(gf);cnb-1(null)* vs *unc-43(gf)* and *cnb-1(null)*.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.004](10.7554/eLife.00518.004)10.7554/eLife.00518.005Figure 2---source data 1.The *unc-43(null)* mutant showed a WT-like lifespan that was epistatic to the longevity effect of *tax-6(RNAi)*, while the *unc-43(gf)* mutant was long-lived.(**A**) The lifespan extension by *tax-6* RNAi required *unc-43*. (**B**) The longevity of *unc-43(n498)* was largely dependent on *daf-16*. (**C**) The *unc-43(n498);cnb-1(ok276)* double mutant lived longer than either single mutant.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.005](10.7554/eLife.00518.005)10.7554/eLife.00518.006Figure 2---figure supplement 1.A screen for the kinase(s) required for the nuclear accumulation of DAF-16::GFP induced by *tax-6(null)*.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.006](10.7554/eLife.00518.006)10.7554/eLife.00518.007Figure 2---figure supplement 2.An *unc-43* RNAi clone from the Ahringer library suppressed the nuclear accumulation of DAF-16::GFP induced by *tax-6(null)*.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.007](10.7554/eLife.00518.007)

To verify that UNC-43 and Calcineurin regulate DAF-16 antagonistically, we examined whether *unc-43(RNAi)* could suppress the longevity of Calcineurin loss-of-function mutants and whether *unc-43(gf)* had the same phenotype as *tax-6(lf)*. Although RNAi knockdown of *tax-6* during adulthood increased the lifespan of WT worms ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---source data 1A](#SD1-data){ref-type="supplementary-material"}), it failed to increase the lifespan of *unc-43(null)* animals ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---source data 1A](#SD1-data){ref-type="supplementary-material"}). This observation is consistent with the hypothesis that Calcineurin removes the activating phosphorylation on DAF-16 caused by UNC-43. We then examined *n498*, an *unc-43 gain-of-function (gf)* allele harboring a missense mutation that results in constitutive activation of the kinase ([@bib42]; [@bib43]). This *unc-43(gf)* allele caused DAF-16::6xHis::GFP to accumulate in the nucleus ([Figure 2D](#fig2){ref-type="fig"}), phenocopying *tax-6(lf)* ([Figure 2A](#fig2){ref-type="fig"}). Furthermore, the *unc-43(n498)* mutant lived 80% longer than the WT animals, and this lifespan extension was largely dependent on *daf-16* ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---source data 1B](#SD1-data){ref-type="supplementary-material"}).

Consistent with UNC-43 activating DAF-16 to prolong lifespan and TAX-6•CNB-1 antagonizing such action, we found that the *unc-43(gf);cnb-1(lf)* double mutant lived even longer than either single mutant ([Figure 2F](#fig2){ref-type="fig"}, [Figure 2---source data 1C](#SD1-data){ref-type="supplementary-material"}).

UNC-43 activates DAF-16 independent of the NSY-1/SEK-1 MAP kinase pathway {#s2-4}
-------------------------------------------------------------------------

Previous studies have shown that UNC-43 activates NSY-1 and SEK-1, two kinases within the MAP kinase pathway, to repress *str-2* expression ([@bib45]). To determine whether UNC-43 activated DAF-16 through NSY-1 (MAPKKK) and SEK-1 (MAPKK), we treated *unc-43(n498)* worms expressing the DAF-16::6xHis::GFP transgene with *nsy-1* and *sek-1* RNAi and found that neither gene affected DAF-16 nuclear accumulation induced by *unc-43(gf)* ([Figure 3A](#fig3){ref-type="fig"}). RNAi against *pmk-2*, which encodes a p38 MAP kinase ([@bib21]; [@bib46]), also had no effect ([Figure 3A](#fig3){ref-type="fig"}). *sek-1* regulates DAF-16 localization in response to oxidative stress ([@bib23]). To ascertain the role of *sek-1* in the nuclear accumulation of DAF-16 induced by *unc-43(gf)*, we crossed the DAF-16::6xHis::GFP animal to a *unc-43(gf);sek-1(null)* double mutant. Similar to the RNAi treatment, the *km4(null)* allele of *sek-1* failed to prevent DAF-16 nuclear localization in *unc-43(gf)* animals ([Figure 3B](#fig3){ref-type="fig"}). Moreover, the *unc-43(gf);sek-1(null)* double mutant did not live a shorter life than *unc-43(gf)* animal ([Figure 3C](#fig3){ref-type="fig"}, [Figure 3---source data 1](#SD2-data){ref-type="supplementary-material"}). Thus, we conclude that UNC-43 does not activate DAF-16 through the NSY-1/SEK-1 MAP kinase pathway.10.7554/eLife.00518.008Figure 3.UNC-43 does not regulate DAF-16 localization through the NSY-1/SEK-1 MAPK kinase pathway.(**A**) RNAi knockdown of *nsy-1, sek-1,* and *pmk-2* failed to block the nuclear accumulation of DAF-16::6xHis::GFP in *unc-43(gf)* mutants. Worms were fed with the indicated RNAi bacteria from hatching and imaged at the L4 stage. (**B**) Similar to *sek-1* RNAi, the *sek-1(km4)* mutation did not eliminate DAF-16 nuclear localization in *unc-43(gf)* worms. (**C**) *km4*, a null allele of *sek-1*, did not shorten the lifespan of WT or *unc-43(gf)* animals. In contrast, *km4* may have slightly extended their lifespan. p=0.001 for *sek-1(null)* vs WT and p=0.047 for *unc-43(gf); sek-1(null)* vs *unc-43(gf)*.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.008](10.7554/eLife.00518.008)10.7554/eLife.00518.009Figure 3---source data 1.*km4*, the null allele of *sek-1*, did not shorten the lifespan of *unc-43(gf)* worms.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.009](10.7554/eLife.00518.009)

UNC-43 can directly bind to and phosphorylate DAF-16 {#s2-5}
----------------------------------------------------

To test whether DAF-16 is a direct substrate of UNC-43, we constructed transgenic strains that co-expressed 3xHA::UNC-43 and 3xFLAG::DAF-16 (MQD522) or expressed either 3xHA::UNC-43 (MQD530) or 3xFLAG::DAF-16 (MQD89) under the control of own promoter. The 3xHA::UNC-43 protein was found in the immunoprecipitate of 3xFLAG::DAF-16 and vice versa ([Figure 4A--B](#fig4){ref-type="fig"}), suggesting that UNC-43 and DAF-16 can form a complex in vivo. Using purified recombinant proteins, we found that GST-UNC-43 but not GST or calmodulin (CAM), was pulled down by nickel beads via 6xHis-DAF-16 ([Figure 4C](#fig4){ref-type="fig"}).10.7554/eLife.00518.010Figure 4.UNC-43 directly binds to and phosphorylates DAF-16.(**A**) 3xHA::UNC-43 co-immunoprecipitated with 3xFLAG::DAF-16 and (**B**) vice versa from lysates of transgenic *C. elegans* expressing both proteins. The transgenic strains are MQD522 (co-expressing 3xHA::UNC-43 and 3xFLAG::DAF-16), MQD530 (expressing 3xHA::UNC-43), and MQD89 (expressing 3xFLAG::DAF-16). (**C**) UNC-43 can directly bind to DAF-16. Purified GST-UNC-43 but not CAM or the GST control was pulled down by Ni-NTA beads through its interaction with 6xHis-DAF-16. A Coomassie gel is shown at the bottom. (**D**)--(**E**) In vitro kinase assays in the presence of \[^32^P\]-γ-ATP, in which purified GST-UNC-43 directly phosphorylated His-tagged DAF-16 (**D**) or DAF-16 (N-F) fragments (**E**). The Coomassie-stained gel is shown below the autoradiograph.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.010](10.7554/eLife.00518.010)

We then asked whether UNC-43 phosphorylates DAF-16. We performed an in vitro kinase assay using purified GST-UNC-43, Ca^2+^/CAM, and 6xHis-DAF-16 in the presence of \[^32^P\]-γ-ATP. GST-UNC-43 readily phosphorylated DAF-16 in vitro ([Figure 4D](#fig4){ref-type="fig"}). To map the phosphorylation site(s), truncated DAF-16 proteins were used as kinase substrates. UNC-43 phosphorylated the DAF-16 N-F fragment (1--267 aa) but not the N-terminal fragment (1--142 aa) ([Figure 4E](#fig4){ref-type="fig"}), suggesting that the phosphorylation site(s) resides in the region containing the forkhead domain (143--267 aa) and/or the C-terminal region (268--508 aa). A mass spectrometry (MS) analysis of the full-length 6xHis-DAF-16 after the in vitro kinase reaction identified two DAF-16 residues T240 and S286 that were phosphorylated by UNC-43 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 5A](#fig5){ref-type="fig"}). T240 and S286 are among the predicted CAMKII sites (RXXS/T or S/TXD). To confirm the MS result, we made two antibodies, one that specifically recognized phospho-T240 and one that specifically recognized phospho-S286. Using these antibodies, we verified that DAF-16 was indeed phosphorylated by UNC-43 at T240 and S286 in vitro ([Figure 5B--C](#fig5){ref-type="fig"}).10.7554/eLife.00518.011Figure 5.UNC-43 phosphorylates S286 of DAF-16, and TAX-6•CNB-1 removes this modification.(**A**) A mass spectrum (neutral loss-triggered MS3) of a DAF-16 peptide phosphorylated at S286 by UNC-43 in vitro. (**B** and **C**) UNC-43 in vitro kinase assays with purified WT or S286A 6xHis-DAF-16 as substrate. DAF-16 phosphorylation was detected with antibodies specific for either phospho-T240 (**B**) or phospho-S286 (**C**). (**D** and **E**) UNC-43 phosphorylates DAF-16 at S286 but not T240 in vivo. Phosphorylated DAF-16::6xHis::GFP was immunoprecipitated from *unc-43(wt)* or *unc-43(gf)* animals using antibodies specific for either phospho-S286 (**D**) or phospho-T240 (**E**) and visualized by blotting with an anti-GFP antibody. Transgenic strains expressing S286A or T240A DAF-16::6xHis::GFP served as negative controls. All strains carry the *daf-16* null allele *mu86* in the background. (**F**) TAX-6•CNB-1 dephosphorylates DAF-16 specifically at S286. Purified 6xHis-DAF-16 was phosphorylated by UNC-43 in vitro and then incubated with purified TAX-6•GST-CNB-1 after heat inactivation of UNC-43. Phospho-T240, phospho-S286, and total DAF-16 levels were assayed by western blotting.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.011](10.7554/eLife.00518.011)10.7554/eLife.00518.012Figure 5---figure supplement 1.Mass spectrum showing a DAF-16 peptide phosphorylated at T240, one of the sites phosphorylated by UNC-43 in vitro.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.012](10.7554/eLife.00518.012)

To confirm whether DAF-16 is phosphorylated in vivo at both sites in an UNC-43-dependent manner, we immunoprecipitated phospho-DAF-16::6xHis::GFP from *daf-16(null);unc-43(gf)* or *daf-16(null)* mutants using the phospho-DAF-16-specific antibodies and followed with anti-GFP immunoblotting. Interestingly, there was a marked increase of DAF-16 S286 phosphorylation, but not T240 phosphorylation, in the *unc-43(gf)* mutant ([Figure 5D--E](#fig5){ref-type="fig"}). S286A and T240A mutations completely abolished phosphorylation on the respective sites ([Figure 5C--E](#fig5){ref-type="fig"}). We thus concluded that UNC-43 phosphorylates DAF-16 specifically on S286. Apparently, T240 phosphorylation by UNC-43 does not occur in vivo under the tested condition.

TAX-6 dephosphorylates DAF-16 at S286 in vitro {#s2-6}
----------------------------------------------

To test whether TAX-6 dephosphorylates DAF-16 at S286, we phosphorylated recombinant DAF-16 in vitro with UNC-43 and then incubated it with purified TAX-6•GST-CNB-1. As shown in [Figure 5F](#fig5){ref-type="fig"}, phosphorylation of DAF-16 at S286 was dramatically reduced by TAX-6•GST-CNB-1, while phosphorylation of T240 remained unchanged.

Phosphorylation of DAF-16 S286 mediates the effect of UNC-43 and TAX-6 {#s2-7}
----------------------------------------------------------------------

To validate the role of S286 in UNC-43- and TAX-6-regulated DAF-16 localization and longevity, we introduced the DAF-16(S286A)::6xHis::GFP transgene into *daf-16(mu86);unc-43(gf)* and *daf-16(mu86);tax-6(lf)* mutants. While DAF-16::6xHis::GFP accumulated in the nuclei of *tax-6(lf)* and *unc-43(gf)* mutants, DAF-16(S286A)::6xHis::GFP distributed diffusely throughout the cell in the same mutant backgrounds ([Figure 6A--B](#fig6){ref-type="fig"}), and the pattern resembled that of DAF-16::6xHis::GFP in WT worms ([Figure 1D](#fig1){ref-type="fig"}). In *C. elegans* whose WT copy of DAF-16 was replaced by DAF-16(S286A), the lifespan extension by either *unc-43(gf)* or *tax-6(lf)* was greatly suppressed ([Figure 6C--D](#fig6){ref-type="fig"}, [Figure 6---source data 1A,B](#SD3-data){ref-type="supplementary-material"}). Thus, the S286 residue is required for DAF-16-dependent effects of *unc-43(gf)* and *tax-6(lf)*, verifying that S286 is the regulatory site. In comparison, the constitutive nuclear localization phenotype of DAF-16(T240A) contradicts with the idea that UNC-43 phosphorylates T240 to promote DAF-16 nuclear accumulation ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Rather, it corroborates the observation that UNC-43 does not phosphorylate T240 in vivo ([Figure 5E](#fig5){ref-type="fig"}).10.7554/eLife.00518.013Figure 6.Phosphorylation of DAF-16 at S286 induces the nuclear accumulation of DAF-16 and extends lifespan.The S286A mutation prevented DAF-16::6xHis::GFP from accumulating in the nucleus in *unc-43(n498gf)* (**A**) or *tax-6(ok2065)* animals (**B**). Unlike the *DAF-16*::*6xHis*::*GFP* transgene, *DAF-16(S286A)*::*6xHis*::*GFP* failed to restore the long lifespan in *daf-16(mu86);unc-43(n498gf)* (**C**) or *daf-16(mu86);tax-6(ok2065)* mutants (**D**). p\<0.001 for *unc-43(gf)* vs *daf-16;unc-43(gf);hqEx182* in (**C**) and *tax-6(null) vs. daf-16;tax-6(null);hqEx221* in (**D**). The S286D mutation caused DAF-16::6xHis::GFP to accumulate in the nucleus (**E**) and extended lifespan in the *daf-16(mu86)* background (**F**). p\<0.001, *daf-16;hqEx174/168 vs. daf-16;hqIs9* in (**F**). 2 hr of heat stress at 28°C, 5 min of paraquat treatment, or 20 hr of food deprivation induced nuclear accumulation of DAF-16::6xHis::GFP in the WT animals but not the *unc-43(n498n1186)* mutants (**G**).**DOI:** [http://dx.doi.org/10.7554/eLife.00518.013](10.7554/eLife.00518.013)10.7554/eLife.00518.014Figure 6---source data 1.The DAF-16(S286A) mutation largely suppressed the longevity induced by either *unc-43(gf)* or *tax-6(null)*, while the DAF-16(S286D) mutation extended lifespan.(**A**) Mutation of DAF-16 S286 to A partially suppressed the *unc-43(gf)* induced longevity. (**B**) Mutation of DAF-16 S286 to A partially suppressed the longevity of *tax-6(null)*. (**C**) *daf-16(mu86)* animals expressing DAF-16 (S286D)::GFP had a longevity phenotype.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.014](10.7554/eLife.00518.014)10.7554/eLife.00518.015Figure 6---figure supplement 1.UNC-43 does not phosphorylate T240 in vivo to promote DAF-16 nuclear accumulation.(**A**) DAF-16(T240A)::6xHis::GFP accumulated in the intestinal nuclei even in the absence *unc-43(gf)*. This is incompatible with T240 being the UNC-43 phosphorylation site because mutating such a site to alanine was expected to inhibit DAF-16 nuclear accumulation. Rather, this result confirms that T240 is an AKT phosphorylation site ([@bib32]). (**B**) 80% of the worms expressing a GFP-tagged DAF-16(T240A-S286A) mutant protein under a *daf-16* promoter in the *unc-43(n498);daf-16(mu86)* background arrested as dauers, and the GFP signal was predominantly in the head neurons. A few individuals escaped dauer arrest and grew into adults. These animals displayed a strong nuclear accumulation of DAF-16(T240A-S286A) in body-wall muscles and hypodermis but a weakened nuclear accumulation in the intestine compared to those expressing WT DAF-16. In comparison, the S286A mutation prevented DAF-16 from accumulating in the nucleus when expressed in the same background ([Figure 6A](#fig6){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.00518.015](10.7554/eLife.00518.015)10.7554/eLife.00518.016Figure 6---figure supplement 2.Similar expression levels of DAF-16(S286D)::6xHis::GFP and DAF-16::6xHis::GFP in three strains used in [Figure 6F](#fig6){ref-type="fig"}.GFP fusion proteins in whole-worm lysates were quantified by anti-GFP WB. SDS-PAGE and anti-tubulin WB show equal loading of total proteins. For *hqEx168* and *hqEx174*, because the transgene arrays were not chromosomally integrated, GFP positive worms were hand-picked under the microscope and pooled to make lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.016](10.7554/eLife.00518.016)

To mimic phosphorylation by UNC-43, we mutated DAF-16 S286 to aspartic acid. When expressed in *daf-16(mu86)* animals, the DAF-16(S286D)::6xHis::GFP protein accumulated in the nucleus, whereas the WT DAF-16::6xHis::GFP protein was cytoplasmic, as expected ([Figure 6E](#fig6){ref-type="fig"}). Moreover, the phosphomimetic of DAF-16, but not the WT version, significantly increased the *C. elegans* lifespan in *daf-16(null*) animals ([Figure 6F](#fig6){ref-type="fig"}, [Figure 6---source data 1C](#SD3-data){ref-type="supplementary-material"}). The effect was not due to higher protein amounts of DAF-16(S286D) because DAF-16(S286D)::6xHis::GFP and DAF-16::6xHis::GFP were expressed at similar levels in these transgenic animals ([Figure 6E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

Taken together, the S286D mutation mimicked the effect of *unc-43(gf)* and *tax-6(lf)* on DAF-16, whereas the S286A mutation of DAF-16 blocked the effects of *unc-43(gf)* and *tax-6(lf)*. Thus, phosphorylation of S286 is critical for CAMKII and Calcineurin to regulate DAF-16 localization and longevity.

UNC-43 transmits signals induced by heat stress, oxidative stress, and starvation to DAF-16 {#s2-8}
-------------------------------------------------------------------------------------------

S286 is different from the known AKT phosphorylation sites (T54, S238, T240, and S312 for DAF-16b) of DAF-16 ([@bib32]). Therefore, UNC-43 and TAX-6•CNB-1 most likely respond to conditions that are distinct from the conditions sensed by AKT in the IIS pathway. In addition to mutations that reduce insulin signaling, various stress conditions, including thermal stress, oxidative stress, and starvation, can trigger translocation of DAF-16 to the nucleus ([@bib15]; [@bib32]). Among the DAF-16 target genes are a wide range of stress response genes, including small heat shock proteins, a superoxide dismutase, catalases, and glutathione S-transferases ([@bib37]; [@bib8]). Transcriptional activation of these target genes by nuclear DAF-16 helps the organism cope with stress, and *daf-16* mutant worms survive stressful conditions less well than WT worms ([@bib48]).

To test whether UNC-43 is required for transmitting stress signals to DAF-16, we crossed *DAF-16::6xHis::GFP* into *unc-43(null)* and compared these animals to WT animals carrying the same transgene. At 20°C, DAF-16::6xHis::GFP displayed a cytoplasmic pattern in either WT or *unc-43(null)* animals. When these worms were transferred to 28°C, DAF-16::6xHis::GFP accumulated in the nucleus in WT worms but remained cytoplasmic in *unc-43(null)* animals ([Figure 6G](#fig6){ref-type="fig"}). Similarly, starvation and paraquat, a chemical that generates reactive oxygen species (ROS) inside the cells, caused DAF-16 to translocate to the nucleus in WT but not *unc-43(null)* worms ([Figure 6G](#fig6){ref-type="fig"}). The results demonstrated that *unc-43* is required for nuclear accumulation of DAF-16 in response to different types of stress.

Crosstalk between insulin signaling and parallel CAMKII/Calcineurin signaling {#s2-9}
-----------------------------------------------------------------------------

The site of DAF-16 that is phosphorylated by CAMKII is different from the site that is phosphorylated by AKT. Moreover, phosphorylation by AKT and CAMKII has opposite effects on DAF-16 activity ([Figures 5 and 6](#fig5 fig6){ref-type="fig"} and [@bib32]). Thus, the IIS pathway (DAF-2) and the CAMKII pathway might work in parallel. In agreement with this hypothesis, reduced IIS and increased phosphorylation of DAF-16 S286, either by *unc-43(gf)* or *tax-6(lf)*, displayed an additive effect on lifespan ([Figure 7A--B](#fig7){ref-type="fig"}, [Figure 7---source data 1A](#SD4-data){ref-type="supplementary-material"}). These two pathways, however, also seem to crosstalk. First, an *unc-43* null allele shortened the *daf-2* lifespan by 31% ([Figure 7C](#fig7){ref-type="fig"}, [Figure 7---source data 1B](#SD4-data){ref-type="supplementary-material"}), indicating that *unc-43* is required for full lifespan extension by *daf-2(e1370)*. This result suggests that part of the signaling from DAF-2 is mediated by UNC-43. However, phosphorylation of DAF-16 S286 seems nonessential for the longevity of *daf-2* animals ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, [Figure 7---source data 1C](#SD4-data){ref-type="supplementary-material"}), suggesting that an additional UNC-43 target(s) is involved in DAF-2 signaling. Second, in the constitutively active *unc-43(gf)* mutant, which has increased phosphorylation on DAF-16 S286 ([Figure 5D](#fig5){ref-type="fig"}), phosphorylation by AKT on T240 is greatly reduced ([Figure 5E](#fig5){ref-type="fig"}). Therefore, in long-lived *unc-43(gf)* animals, phosphorylation on these two residues appears to be coordinated, but it is unclear how this coordination occurs. The AKT kinase activity may be reduced in *unc-43(gf)*, or phospho-S286 DAF-16 may be a poor substrate for AKT. In either case, dampened phosphorylation on the AKT site may be expected to prevent DAF-16 from forming a complex with the 14-3-3 protein, which has been shown to bind to and sequester AKT-phosphorylated FOXO (DAF-16 or mammalian FOXO3) in the cytoplasm ([@bib5]; [@bib3]; [@bib30]). Consistently, we found that *unc-43(gf)* reduced the amount of DAF-16-associated 14-3-3 without affecting the total amount of 14-3-3 ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). It remains to be seen whether S286 phosphorylation directly or indirectly promotes DAF-16 nuclear accumulation.10.7554/eLife.00518.017Figure 7.The longevity of *daf-2* mutants was partially suppressed by *unc-43(null)* and further enhanced by *unc-43(gf)* or *tax-6(null)*.*unc-43(n498)*, a gain-of-function allele (**A**), and *tax-6(ok2065),* a null allele (**B**), each extended lifespan in the WT background and further enhanced the longevity of *daf-2(RNAi)* animals. (**C**) The *daf-2(e1370);unc-43(n498n1186)* double mutant lived a significantly shorter life than *daf-2(e1370)*, while the *unc-43(n498n1186)* mutant had a WT-like lifespan. In (**A**) and (**B**), p\<0.001 for WT vs *tax-6(null)* or *unc-43(gf)*, *unc-43(gf);daf-2(RNAi) vs. daf-2(RNAi)* or *unc-43(gf),* and *tax-6(null);daf-2(RNAi) vs. daf-2(RNAi)* or *tax-6(null)*. In (**C**), p\<0.001 for *daf-2 vs. daf-2;unc-43(null)*, p=0.61 for *unc-43(null) vs*. WT in a lifespan assay at 25°C.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.017](10.7554/eLife.00518.017)10.7554/eLife.00518.018Figure 7---source data 1.The long lifespan of *daf-2(RNAi)* animals was further extended by either *unc-43(gf)* or*tax-6(null),* but shortened by *unc-43(null)*.(**A**) Both *unc-43(gf)* and *tax-6(null)* further increased the lifespan of *daf-2* RNAi animals. (**B**) *unc-43* was partially required for the long lifespan of *daf-2* animals. (**C**) The DAF-16 S286A mutation appears not to affect the *daf-2* longevity.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.018](10.7554/eLife.00518.018)10.7554/eLife.00518.019Figure 7---figure supplement 1.The DAF-16 S286A mutation appears not to affect daf-2 longevity.(**A**)--(**B**) Two repeat experiments showing similar lifespan extension by *daf-2* RNAi of *daf-16(mu86)* worms expressing DAF-16::6xHis::GFP (*hqEx192* and *hqEx193*) or DAF-16(S286A)::6xHis::GFP (*hqEx365* and *hqEx366*). n ≥ 61.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.019](10.7554/eLife.00518.019)10.7554/eLife.00518.020Figure 7---figure supplement 2.In the unc-43(n498gf) mutant, in which DAF-16 accumulates in the nucleus, the amount of DAF-16/14-3-3 complex is reduced.DAF-16::6xHis::GFP was immunoprecipitated from worms carrying a WT or the *gf* allele of *unc-43*. The amount of 14-3-3 present in the lysate and that associated with DAF-16::6xHis::GFP were visualized by WB using an antibody that recognizes both 14-3-3 proteins (FTT-2 and PAR-5) in *C. elegans*.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.020](10.7554/eLife.00518.020)

While IIS and CAMKII/Calcineurin signaling act largely in parallel with each other, it is unclear what would happen if one pathway was in a state to inhibit DAF-16 while the other pathway was in a state that would activate it. To genetically mimic this scenario, we combined *daf-2* RNAi with either *unc-43(null)* or *tax-6(jh107)*, a constitutively active *tax-6(gf)* allele in which the autoinhibitory domain was deleted ([@bib28]). DAF-16::GFP was cytoplasmic in *unc-43(null)* or *tax-6(gf)*, but nuclear DAF-16::GFP was clearly visible above the cytoplasmic background in *daf-2(RNAi)*, *daf-2(RNAi);unc-43(null)*, or *daf-2(RNAi);tax-6(gf)* mutants ([Figure 8A](#fig8){ref-type="fig"}). We also combined *daf-18* RNAi, which enhances IIS to inhibit DAF-16 ([@bib39]), with *unc-43(gf)* or *tax-6(lf)*, which activates DAF-16. In both cases, the nuclear accumulation induced by *unc-43(gf)* or *tax-6(lf)* was greatly diminished by *daf-18* RNAi ([Figure 8B](#fig8){ref-type="fig"}). Therefore, under conditions in which there is a conflict between IIS and CAMKII/Calcineurin signaling toward DAF-16, the insulin signaling pathway appears to dominate.10.7554/eLife.00518.021Figure 8.Insulin signaling overpowers CAMKII and Calcineurin in regulation of DAF-16 localization in *C. elegans*.(**A**) *tax-6(gf)* or *unc-43(null)* failed to abolish DAF-16 nuclear accumulation induced by *daf-2(RNAi)*. (**B**) *tax-6(null)* or *unc-43(gf)* failed to overcome the inhibition of DAF-16 nuclear localization by *daf-18(RNAi)*. (**C**) A model showing the regulation of DAF-16 (FOXO) by insulin signaling, UNC-43 (CAMKII), and TAX-6•CNB-1 (Calcineurin).**DOI:** [http://dx.doi.org/10.7554/eLife.00518.021](10.7554/eLife.00518.021)

Based on the experimental evidence above, we propose a model ([Figure 8C](#fig8){ref-type="fig"}) in which DAF-16 integrates hormonal signals and stress signals transmitted by the IIS pathway (from DAF-2 to AKT) and CAMKII (UNC-43), respectively. CAMKII and the counterbalancing phosphatase Calcineurin (TAX-6•CNB-1) act in parallel and coordinately with the IIS pathway to regulate DAF-16 activity.

Mammalian CAMKII and Calcineurin also regulate phosphorylation of FOXO3 at a conserved serine residue {#s2-10}
-----------------------------------------------------------------------------------------------------

Sequence analysis of FOXO proteins revealed that DAF-16 S286, the CAMKII phosphorylation site, is widely conserved in nematode species, zebra fish, frogs, mice, and humans ([Figure 9A](#fig9){ref-type="fig"}). It is equivalent to S298 of mouse FOXO3 (mFOXO3) and S299 of human FOXO3 (hFOXO3) ([Figure 9A](#fig9){ref-type="fig"}), and may be the equivalent of S303 of human FOXO1 or S300 of mouse FOXO1 (not shown). Such conservation suggests that mammalian FOXO proteins are likely regulated by CAMKII and Calcineurin.10.7554/eLife.00518.022Figure 9.CAMKII and Calcineurin regulate phosphorylation of mouse FOXO3 at S298.(**A**) Sequence alignment of selected FOXO homologs from nematode species to human. The region containing DAF-16 T240 and S286 is shown. T240 is conserved in all FOXO homologs. S286 is less conserved, but it is found in many nematode FOXOs and a number of vertebrate FOXOs. The DAF-16 or mouse FOXO3 residues phosphorylated in vitro by UNC-43 or CAMKIIA are boxed, with amino acid positions shown above or below. GFP-tagged mouse CAMKIIA or CAMKIIB, or Myc-tagged human Calcineurin A was transfected either alone or with FLAG-tagged mouse FOXO3 into HEK293T cells. Immunoprecipitation of FLAG-FOXO3 pulled down both CAMKII isoforms (**B**) and Calcineurin (**C**). (**D**) Two FOXO3 fragments P2 and P3, corresponding to amino acids 154--259 and 259--409, were phosphorylated in vitro by CAMKIIA in the presence of \[^32^P\]-γ-ATP. The input protein substrates are shown at the bottom. (**E**) Mass spectrum showing a FOXO3 peptide phosphorylated by CAMKIIA at S298. (**F**) CAMKIIA phosphorylates FOXO3 at S298 in vivo. FLAG-FOXO3 immunoprecipitated from HEK293T cells co-transfected or not with CAMKIIA was digested with trypsin and subjected to mass spectrometry analysis. Spectral counts (i.e., number of observations) of the indicated phospho-S/T are normalized to the total spectral counts of FLAG-FOXO3.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.022](10.7554/eLife.00518.022)10.7554/eLife.00518.023Figure 9---figure supplement 1.Analysis of FOXO3 phosphorylation sites in vivo.Mass spectra showing two phosphorylation sites S252 (**A**) and S279 (**B**) identified from FLAG-mFOXO3 expressed in HEK293T cells. Mass spectrum identifying a third phosphorylation site S298 is shown in Figure 9E.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.023](10.7554/eLife.00518.023)10.7554/eLife.00518.024Figure 9---figure supplement 2.CAMIIA had no effect on S253 phosphorylation of human FOXO3 (corresponding to S252 of mouse FOXO3) in vivo.(**A**) Transfection of CAMKIIA into HEK293T cells failed to increase phosphorylation of hFOXO3 at S253. (**B**) Overexpression of Calcineurin A into HEK293T cells did not reduce phosphorylation of human FOXO3 at S253, which was recognized using an antibody specific for S253 phosphorylation.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.024](10.7554/eLife.00518.024)10.7554/eLife.00518.025Figure 9---figure supplement 3.In vitro Calcineurin phosphatase assay on FOXO3.(**A**) The S298-containing P3 fragment of mouse FOXO3 was first phosphorylated in vitro by CAMKIIA in the presence of \[^32^P\]-γ-ATP, then incubated with Calcineurin after the in vitro kinase reaction. Calcineurin markedly reduced the CAMKIIA-induced phosphorylation on P3. (**B**) The P2 fragment of mouse FOXO3 that was phosphorylated by CAMKIIA in vitro and then incubated with Calcineurin after inactivation of the kinase. Calcineurin had no effect on mFOXO3 S252 phosphorylation as visualized by immunoblotting with a phospho-S252 specific antibody.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.025](10.7554/eLife.00518.025)

To determine if this is true, we first expressed a FLAG-tagged mouse FOXO3 together with a GFP-tagged mouse CAMKII alpha (CAMKIIA) or beta (CAMKIIB) isoform, or a Myc-tagged human Calcineurin A (CnA) in HEK293T cells, and found that CAMKII and CnA both interact with FOXO3 ([Figure 9B--C](#fig9){ref-type="fig"}). Next, we asked whether CAMKII phosphorylates FOXO3 in vitro. Purified GST fusion proteins containing five non-overlapping fragments of FOXO3 ([@bib29]) were incubated with an active recombinant human CAMKIIA. CAMKIIA robustly phosphorylated the P2 and P3 fragments but not the others ([Figure 9D](#fig9){ref-type="fig"}), placing the phosphorylation sites within aa 154--409. Mass spectrometry and mutagenesis studies of the full-length mFOXO3 or the P2 and P3 fragments from the in vitro kinase assay mapped the CAMKIIA phosphorylation sites to S252, S279, and S298 (not shown). The same sites were also identified from FLAG-mFOXO3 co-expressed with CAMKIIA in HEK293T cells ([Figure 9E](#fig9){ref-type="fig"}, [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}). However, only mFOXO3 S298, which corresponds to DAF-16 S286, had a significant increase in phosphorylation when cells were co-transfected with CAMKIIA ([Figure 9F](#fig9){ref-type="fig"}). This shows that S298 is the principle CAMKIIA phosphorylation site in vivo. S252 in mouse FOXO3 or S253 in human FOXO3, the counterpart of DAF-16 T240 ([Figure 9A](#fig9){ref-type="fig"}), is a highly conserved AKT phosphorylation site ([@bib5]). Using a specific antibody, we found that neither CAMKIIA nor Calcineurin regulated phosphorylation of endogenous human FOXO3 at S253 in HEK293T cells ([Figure 9---figure supplement 2](#fig9s2){ref-type="fig"}). Moreover, Calcineurin can reduce the phosphorylation of the FOXO3-P3 fragment (containing S298) by CAMKIIA, but not that of the P2 fragment (containing S252) ([Figure 9---figure supplement 3](#fig9s3){ref-type="fig"}). Taken together, these results demonstrate that mammalian CAMKII and Calcineurin regulate phosphorylation of FOXO3 at the same conserved site as in *C. elegans* (S298 in mouse FOXO3 and S286 in DAF-16).

A recent study by Ozcan et al. shows that four non-AKT phosphorylation sites are involved in the activation of murine FOXO1 by CAMKIIγ, likely through the p38 MAP kinase, in glucagon-stimulated hepatocytes ([@bib40]). Serine 300 of mouse FOXO1, the equivalent of S298 of mouse FOXO3, is not among them (S246, S295, S467, and S475). To find out whether the CAMKIIA isoform phosphorylates FOXO1 in the same way as it does FOXO3, we expressed a FLAG-tagged human FOXO1 in HEK293T cells co-transfected or not with CAMKIIA. Mass spectrometry analysis identified three CAMKIIA-regulated phosphorylation sites equivalent to mouse FOXO1 S295, S467, and S475 (not shown). This agrees with the findings by Ozcan et al. and suggests that CAMKII directly phosphorylates FOXO3 but not FOXO1 in mammals.

Lastly, we determined whether CAMKII and Calcineurin regulate the transcriptional activity of FOXO3. Mammalian CAMKII can be activated by autophosphorylation at threonine 286 ([@bib36]; [@bib44]). Mutation of this residue to A or D results in a kinase dead or constitutively active form of CAMKII, respectively ([@bib11]). Using a luciferase reporter assay, we found that the transcriptional activity of FOXO3 was indeed stimulated by CAMKIIA in a way that required S298 of FOXO3 ([Figure 10A](#fig10){ref-type="fig"}) and T286 of CAMKIIA ([Figure 10B](#fig10){ref-type="fig"}), and further enhanced by the constitutively active CAMKIIA mutant ([Figure 10C](#fig10){ref-type="fig"}). Consistently, expression of Calcineurin significantly inhibited the transcriptional activity of FOXO3 ([Figure 10D](#fig10){ref-type="fig"}). From these results, we conclude that CAMKIIA and Calcineurin oppose each other in regulating the transcriptional activity of mouse FOXO3 through phosphorylation or dephosphorylation at S298. This mechanism is conserved from *C. elegans* to mammals.10.7554/eLife.00518.026Figure 10.CAMKII and Calcineurin regulate the transcriptional activity of FOXO3.(**A**)--(**D**) HEK293T cells were transfected with the indicated constructs together with a 3xIRS-firefly luciferase reporter and a TK-renilla luciferase reporter. Mean ± SD of firefly/renilla luciferase activity relative to the empty vector transfection is plotted (\*\*\*p\<0.0001, Student's *t*-test, n = 3; *N.S*. for not significant). (**A**) Co-transfection of CAMKIIA stimulated the transcriptional activity of WT FOXO3 but not the FOXO3 (S298A) mutant. (**B**) WT but not an inactive T286A mutant CAMKIIA, transcriptionally activated FOXO3. (**C**) A constitutively active T286D mutant CAMKIIA further enhanced FOXO3 activity compared to WT CAMKIIA. (**D**) FOXO3 was transcriptionally inhibited by Calcineurin A, and further inhibited if Calcineurin A and Calcineurin B were both expressed.**DOI:** [http://dx.doi.org/10.7554/eLife.00518.026](10.7554/eLife.00518.026)

Discussion {#s3}
==========

CAMKII and Calcineurin constitute a previously uncharacterized signaling branch that targets DAF-16 {#s3-1}
---------------------------------------------------------------------------------------------------

Our data suggest that CAMKII (UNC-43) and Calcineurin (TAX-6•CNB-1), by phosphorylating or de-phosphorylating serine 286 of DAF-16, extend or shorten the lifespan of *C. elegans*. The direct, antagonistic nature of these two enzymes also raised an interesting possibility that, with their opposing effects on DAF-16 and a common activating signal (Ca^2+^/CAM), UNC-43 and TAX-6•CNB-1 would constitutively negate each other and have essentially no control of DAF-16. However, this outcome most likely does not occur because of the difference in the spatial distribution and temporal activation profiles of the two enzymes. TAX-6 and CNB-1, similar to DAF-16, are expressed in most cells in *C. elegans* ([@bib38]; [@bib2]; [@bib26]; [@bib8]). In contrast, *unc-43* promoter-driven GFP was only detected in neurons and the intestine ([@bib17]). We also detected UNC-43 primarily in the nervous system (not shown).

At the subcellular level, the TAX-6::GFP fusion protein is distributed diffusely throughout the cytoplasm and inside the nucleus ([@bib26]; [@bib8]). In contrast, the CFP::UNC-43 fusion protein is concentrated on perinuclear structures and clusters in neurites ([@bib47]). Temporally, Ca^2+^-activated CAMKII phosphorylates another molecule of CAMKII at T286 to convert it to a Ca^2+^/CAM-independent kinase, prolonging the kinase activity after the initial activation ([@bib10]). CAMKII can also be activated by ROS at low Ca^2+^ concentrations ([@bib10]). In mammalian cells, inhibition of Calcineurin by cytoplasmic CAMKII and inhibition of CAMKII by Calcineurin have both been reported ([@bib33]; [@bib25]), suggesting that the balance is intricately maintained. Therefore, in the case of the simultaneous activation of CAMKII and Calcineurin by Ca^2+^/CAM, either the kinase or the phosphatase could dominate the regulation of DAF-16 either locally (e.g., cytoplasm vs nucleus) or for certain time windows. This balance likely fine-tunes the DAF-16 activity in response to a changing environment.

CAMKII responds to a variety of stress signals {#s3-2}
----------------------------------------------

It is likely that UNC-43/Calcineurin is responsible for activating DAF-16 when worms experience a variety of stress signals, including heat stress, oxidative stress, or prolonged starvation ([Figure 6G](#fig6){ref-type="fig"}). Food deprivation acts through UNC-43 to suppress spontaneous sex-muscle contraction in *C. elegans* males ([@bib27]). Reported in HEK293T cells, human FOXO3 is phosphorylated at non-AKT sites under stress conditions such as heat shock or H~2~O~2~ treatment ([@bib6]). ROS-induced oxidation of two methionine residues activates CAMKII, and this activation can occur under conditions of low Ca^2+^ ([@bib10]). Thus, CAMKII is perfectly equipped to transmit ROS signaling and calcium signaling, and phosphorylation of FOXO3 by CAMKII may play a highly conserved role in the stress response, from worms to humans.

Daf-16 is not the only substrate of worm Calcineurin that regulates lifespan {#s3-3}
----------------------------------------------------------------------------

To date, DAF-16 is the only biochemically and genetically proven substrate of TAX-6•CNB-1, but it is not the only substrate involved in lifespan regulation by Calcineurin. Inactivation of CRTC-1, a coactivator of CREB, contributes to the longevity of *tax-6(lf)* animals ([@bib34]). Hence, CRTC-1 is an excellent candidate, although it has not been shown that TAX-6•CNB-1 directly dephosphorylates CRTC-1. There may be additional substrates. Regardless, the discoveries made thus far jointly provide a good explanation for the large but incomplete suppression of *tax-6(lf)* longevity by *daf-16(null)* ([@bib8]).

Dysregulation of FOXO3 by CAMKII and Calcineurin may be linked to diabetes {#s3-4}
--------------------------------------------------------------------------

Post-transplant new-onset diabetes mellitus (NODM) is a frequent and serious complication for organ transplant patients. One of the NODM risk factors is the use of Calcineurin inhibitors, such as cyclosporin A and FK506, which suppress immune-rejection of donor organs ([@bib14]). In light of this work, we propose that sustained activation of FOXO3 resulting from chronic inhibition of Calcineurin may cause NODM in transplant patients. Given the conservation and broad tissue distribution of CAMKII, Calcineurin, and FOXO3, the regulatory mechanism uncovered in this study likely plays a role in many physiological functions.

Materials and methods {#s4}
=====================

*C. elegans* strains {#s4-1}
--------------------

All strains were cultured at 20°C following standard protocols unless otherwise indicated ([@bib4]). Double mutants were made using standard genetic methods, and the genotypes were confirmed using PCR or PCR followed by sequencing. The strains and oligos used in the study are listed in [Supplementary file 1A,B](#SD5-data){ref-type="supplementary-material"}, respectively.

Antibodies {#s4-2}
----------

The following antibodies were purchased: Mouse anti-Actin (Sigma-Aldrich, St Louis, MO), Mouse anti-tubulin (Sigma-Aldrich), mouse anti-CAM (Millipore, Billerica, MA), mouse anti-FLAG (Sigma-Aldrich), anti-FLAG M2 Affinity Gel (Sigma-Aldrich), rabbit anti-GFP (Abmart, Shanghai, China), mouse anti-GFP (Roche, Basel, Switzerland), rabbit anti-GFP (Invitrogen, Carlsbad, CA), rabbit anti-GST (GeneSci, Beijing, China), monoclonal anti-HA agarose (Sigma-Aldrich), rabbit anti-mFOXO3(phospho-S252)/hFOXO3(phospho-S253) (Cell Signaling, Danvers, MA), Mouse anti-Myc (Santa Cruz Biotechnology, Dallas, TX), goat anti-mouse IgG HRP (Jackson Immuno Research, West Grove, PA), and goat anti-rabbit IgG HRP (BaiHuiZhongYuan, Beijing, China). Rabbit α-HA and monoclonal mouse α-DAF-16 antibodies were made at the antibody center of the NIBS, Beijing. A single-chain anti-GFP antibody was produced as described before ([@bib24]) and cross-linked to NHS-activated Sepharose 4 Fast Flow beads (GE Healthcare, Piscataway Township, NJ). We called this GBP beads. To produce the DAF-16 antibody, full-length DAF-16b was cloned into the His-tag vector pET-28a, expressed in *Escherichia coli* BL21, and purified by Ni-NTA resin (Qiagen). Rabbit α-DAF-16b(pT240) and α-DAF-16b(pS286) antibodies were custom made and affinity purified at Abmart (Shanghai, China) using the synthetic DAF-16 phospho-peptides 'RERSN(pT)IETTT-C' and 'SIQTI(pS)HDLYD-C,' respectively. A Rabbit polyclonal anti-human 14-3-3 antibody that recognizes both *C. elegans* 14-3-3 proteins was a gift from Dr Yamei Wang (Xiamen University, China).

Plasmids {#s4-3}
--------

The *daf-16* constructs were subcloned and further modified from a *P*~*daf-16*~*::daf-16b::gfp* construct described previously (the *daf-16b* isoform used to be called *daf-16a2*) ([@bib15]). The GST-CNB-1 and TAX-6 bacterial expression constructs were modified from the GST-CNB-1 and GST-TAX-6 plasmids reported before ([@bib2]). The *unc-43* expression constructs were made from *unc-43* cDNAs that were amplified from a *C. elegans* cDNA library. The constructs expressing full-length or truncated mouse FOXO3 have been described ([@bib29]), and the FOXO3-P2-S252A mutant was made by site-directed mutagenesis. The CAMKIIA and CAMKIIB expression constructs have described ([@bib12]). The Myc-CnA and Myc-CnB expression constructs under the CMV promoter were subcloned from 'pET15b CnA CnB' (Addgene). The FKRE-luciferase expression vector was kindly provided by Dr Azad Bonni (Harvard Medical School).

Purified proteins {#s4-4}
-----------------

GST-CNB-1 and TAX-6 were co-expressed in *E. coli* BL21 and affinity purified using glutathione Sepharose (GE Healthcare) in PBS containing 0.5% NP-40 following standard protocols. GST-DAF-16(N) and GST-DAF-16(N-F) were purified in the same manner. Recombinant GST-UNC-43 was purified as described above but using a buffer containing 50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.5% NP-40. Recombinant 6xHis-DAF-16 and 6xHis-DAF-16-6AM were expressed in BL21 and affinity purified using Ni-NTA agarose resin (Qiagen) in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, and 0.5% NP-40. His-tagged proteins were eluted off beads by adding 250 or 500 mM imidazole to the buffer after a 30 mM imidazole wash. Eluted proteins underwent buffer exchange and were concentrated using Centricon purifying units (Millipore) with 10-kDa (for TAX•GST-CNB-1) or 50-kDa (for other proteins) cutoffs to 0.5--1.0 mg/ml protein in storage buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.5% NP-40, 10% glycerol); the resulting solutions contained \>1 mM glutathione or \>5 mM imidazole. Bovine Calmodulin and human Calcineurin were purchased from Merck. Active human GST-CAMKIIA was ordered from Sigma. Recombinant mFOXO3 P1-P5 fragments were purified as described ([@bib29]).

Lifespan assay {#s4-5}
--------------

Lifespan assays were carried out at 20°C unless otherwise indicated. To synchronize worms, twenty adult worms were allowed to lay eggs on NGM plates for 4 hr before being removed. After the progeny grew to the L4 stage, they were transferred to new plates (10 worms/plate). At least ten plates (100 worms) were used for the lifespan assay of each strain or RNAi treatment. Worms were transferred to fresh plates every 2 days until they ceased laying egg, after which worms were transferred to fresh plates every week. For lifespan assays that involved or would be compared with the *unc-43(gf)* mutant, 50 μg/ml FUDR was added to the plates to prevent its Egl (egg-laying defective) phenotype from interfering with lifespan measurement. In these experiments ([Figure 2---source data 1B](#SD1-data){ref-type="supplementary-material"}; [Figure 2---source data 1C](#SD1-data){ref-type="supplementary-material"}; [Figure 3---source data 1](#SD2-data){ref-type="supplementary-material"}; [Figure 6---source data 1A](#SD3-data){ref-type="supplementary-material"}; [Figure 6---source data 1C](#SD3-data){ref-type="supplementary-material"}; [Figure 7---source data 1A](#SD4-data){ref-type="supplementary-material"}), worms were transferred to fresh plates every 4 days until death. Live worms were scored every 2 days. Worms were considered dead if they failed to respond to gentle touches with a worm pick on the head and tail. Worms that had internally hatched larvae ('bagged') or ruptured vulvae ('exploded') or crawled off the agar surface were censored. SPSS (Statistical Package for the Social Sciences) software was used for the statistical analysis of the lifespan data, and the log-rank method was used to calculate p values.

RNAi {#s4-6}
----

RNAi assays were performed at 20°C using the feeding method as previously described ([@bib18]). Worms were fed RNAi bacteria from the time of hatching unless otherwise indicated. *E. coli* HT115(DE3) transformed with pAD12, an empty RNAi vector ([@bib1]), was used as a control. pTL13 is an RNAi construct targeting *unc-43*, which we generated by inserting a 332-bp cDNA fragment of *unc-43* into the multiple cloning sites of pAD12. The other RNAi bacterial strains were obtained from the Ahringer RNAi library.

Pull down assay {#s4-7}
---------------

To examine the interaction between DAF-16 and TAX-6, 6xHis-DAF-16 was incubated with purified TAX-6•GST-CNB-1 complex in the presence of 2 μg CAM and 30 μl pre-washed Ni-NTA agarose resin (Qiagen) in binding buffer A (50 mM Tris, pH 8.0, 100 mM NaCl, 4 mM CaCl~2~, 2 mM MgCl~2~, 0.5% NP-40) at 4°C for 2 hr. The beads were then washed with washing buffer A (50 mM Tris, pH 8.0, 100 mM NaCl, 4 mM CaCl~2~, 2 mM MgCl~2~, 0.5% NP-40, 30 mM imidazole) and eluted with SDS loading buffer. Samples were resolved by SDS-PAGE and stained with Coomassie blue.

For DAF-16 and UNC-43 binding, 6xHis-DAF-16 was incubated with purified GST-UNC-43 and CAM in the presence of 30 μl pre-washed Ni-NTA agarose in binding buffer A without MgCl~2~. After binding, beads were washed with washing buffer A without MgCl~2~ and eluted with SDS loading buffer. The samples were resolved by replicate SDS-PAGE gels, one for Coomassie blue or silver staining, and the other for western blots with anti-GST, anti-DAF-16 or anti-CAM antibodies.

To map the TAX-6 binding site on DAF-16, 5 µg of GST or GST-tagged DAF-16 fragments were incubated with TAX-6::GFP-containing worm lysate (∼15 µg/µl proteins in 300 μl of 20 mM Tris, pH 8.0, 1% NP-40, 10% glycerol, 1x Protease Inhibitor Cocktail, EDTA free, Roche) and pre-washed glutathione beads at 4°C for 1 hr. The beads were washed three times and eluted with 1x SDS loading buffer.

Immunoprecipitation {#s4-8}
-------------------

Mixed-stage worms were cultured at 20°C on five 100-mm HG plates seeded with OP50, harvested, and washed with M9 buffer to yield 200--500 μl of packed worms. Then, 200 μl of packed worms was mixed with 200 μl of 2x lysis buffer A, B, or C (see below) and 800 μl of 0.5-mm diameter glass beads. The mixture was lysed using FastPrep-24 (MP Biomedicals) at 6.5 m/s, 20 s/pulse × 3 pulses with 5-min intervals on ice. Worm lysates were cleared by centrifugation at 13,000 rpm for 30 min. For anti-GFP and anti-FLAG IPs, the supernatant was incubated with GBP beads or anti-FLAG M2 beads for 1--2 hr. For the phospho-DAF-16 IP, the supernatant was incubated with 10 μl of the antibody specific for DAF-16(pT240) or DAF-16(pS298) and 30 μl of pre-washed protein A and protein G beads (mixed at 1:1) for 2 hr. After incubation with the lysates, the beads were washed 2--3 times with 1x lysis buffer, 5 min each time, and boiled in 2x SDS loading buffer for western blot analysis. All steps, from making the lysates to eluting the beads, were performed at 4°C.

Lysis buffers {#s4-9}
-------------

1x lysis buffer A (for IP of DAF-16 and TAX-6): 20 mM Tris pH 8.0, 1% NP-40, 10% glycerol, 2 mM EDTA, 1x PIC (Protease Inhibitor Cocktail, EDTA free; Roche).

1x lysis buffer B (for IP of DAF-16 and UNC-43): 50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, 10% glycerol, 1x PIC, 1x PhosSTOP (Roche).

1x lysis buffer C (for IP of phospho-DAF-16): 50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% SDS, 0.25% sodium deoxycholate, 1% NP-40, 2 mM EDTA, 1x PIC, 1x PhosSTOP.

Immunoprecipitation of FLAG-FOXO3 from HEK293T cells was performed as described ([@bib49]).

In vitro kinase assay {#s4-10}
---------------------

2 μg of purified recombinant GST-UNC-43 (or 5 μg of purified active human GST-CAMKIIA) was incubated with 2 μg of CAM and 2--5 μg of purified 6xHis- or GST-tagged DAF-16 (or GST-FOXO3) in the kinase reaction buffer (50 mM PIPES, pH 7.0, 10 mM MgCl~2~, 4 mM CaCl~2~, 100 μM ATP, 1x PIC) in the presence or absence of \[^32^P\]-γ-ATP at 30°C for 15 min. Proteins were resolved by SDS PAGE and analyzed by autoradiography or WB with anti-DAF-16(pT240) or anti-DAF-16(pS286) antibodies.

In vitro phosphatase assay {#s4-11}
--------------------------

The kinase reactions, performed as described above, were shifted to 60°C for 10 min to inactivate UNC-43 or CAMKIIA. Then the samples were incubated or not with 5 μg of TAX-6•GST-CNB-1 or Calcineurin in phosphatase buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 6 mM MgCl~2~, 1 mM CaCl~2~, 1x PIC) in the presence of 2 μg CAM at 30°C for 30 min. The sample were resolved by SDS-PAGE and analyzed by autoradiography or by WB with antibodies specific for DAF-16(pT240), DAF-16(pS286), or mFOXO3(S252)/hFOXO3(S253).

Daf-16 localization {#s4-12}
-------------------

Worms were cultured at 20°C on NGM plates from eggs laid within a 4-hr period and imaged at the L4 stage unless otherwise indicated. As soon as worms were removed from incubation, they were mounted on slides and imaged immediately. For the starvation challenge, approximately 100 L4 worms were placed on an empty plate and kept at 20°C for 20 hr before imaging. For the heat stress challenge, well-fed L4 worms on bacterial food were shifted to 28°C for 2 hr. Parallel samples were maintained at 20°C on food as controls. All GFP and DIC images were taken using a Zeiss Axio Imager M1 microscope at 400-fold magnification.

Mass spectrometry analysis {#s4-13}
--------------------------

Coomassie blue-stained bands corresponding to in vitro phosphorylated DAF-16 or FOXO3 fragments, or FLAG-FOXO3 immunoprecipetated from 293T cells were destained and in-gel digested with trypsin. LC-MS/MS analyses of the resulting peptides were carried out on an LTQ-Orbitrap (ThermoFisher Scientific) or LTQ-Orbitrap Velos (ThermoFisher Scientific) as described before with slight modifications ([@bib31]). CID MS2 with neutral-loss triggered MS3 spectra were collected on LTQ-Orbitrap and HCD MS2 spectra were collected on LTQ-Orbitrap Velos. The MS2 or MS3 data were searched against the *C. elegans* protein database (for DAF-16) or the NCBI mouse protein database (for FOXO3). The pLabel software was used for spectral labeling ([@bib50]).

Mammalian cell culture, transfection, and luciferase assay {#s4-14}
----------------------------------------------------------

HEK293T cells were maintained in DMEM medium supplemented with 10% fetal bovine serum (FBS) at 5% CO~2~. Transfection was carried out using Lipofectamine 2000 (Invitrogen), and the luciferase assays were carried out using the Dual-Luciferase assay kit (Promega).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://www.elifesciences.org/the-journal/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for choosing to send your work entitled "CAMKII and Calcineurin Regulate the Lifespan of *C. elegans* through the FOXO Transcription Factor DAF-16" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This paper is of substantial interest based on data revealing novel interactions between *daf-16* in *C. elegans* and the orthologs of calcineurin and CamKII, powerful regulators in the mammalian immune system as well as metabolism. The data strongly support the authors' hypothesis that *daf-16* function is positively regulated by phosphorylation by the latter and negatively regulated by dephosphorylation of the former. Furthermore, stress responses appear to be mediated by this system in controlling life span in worms. However, recent data published by Ozcan et al (cited in the present paper but not discussed in sufficient detail) have revealed phosphorylation of FOXO by CamKII, nuclear translocation, and phospho sites that are distinct from AKT sites, so these findings are not completely novel. Nonetheless, this paper extends our information substantially and the impact would be even further strengthened with extension of the findings into a mammalian system. Major concerns are noted below:

1\) All the data presented related to phosphorylation/dephosphorylation have been produced through the use of expressed tagged constructs. None of the conclusions are supported by isolations of the endogenous proteins. Although the bulk of the claims based on biochemical analysis are well supported by genetic studies, direct evidence of interactions and covalent modification of endogenous proteins would strengthen the paper. It is suggested, but not required, that the authors consider using antibodies against the endogenous proteins to confirm their data.

2\) The T240 site does not appear to be regulated, although again these relevant data are from expressed tagged proteins. There are no genetic studies for this site provided, which would strengthen the concept that this site is not involved.

3\) The conclusions of the paper would be substantively extended and the impact strengthened if the authors could provide evidence that this site of S286 of regulation of FOXO protein in mouse and human were operational. Good reagents are available for such studies, which would be easy to do in terms of both demonstrating phosphorylation/dephosphorylation as well as nuclear/cytoplasmic localization. In this regard, even though S286 is conserved in FOXO3, S303 in FOXO1, the equivalent of S299 in FOXO3, was not identified as a site whose phosphorylation was increased by CaMKIIg by Ozcan et al., and most of the reported sites were in Ser-Pro motifs, possibly phosphorylated as a result of p38 activation.

4\) The sequence around DAF-16 S286(SIQTISHDLYD) is not that of a typical site for phosphorylation by CaMKII, which is a basophilic kinase, and is not predicted by Scansite to be a CaMKII site, even at low stringency, despite the authors' in vitro evidence that CaMKII can directly phosphorylate S286. All the mapped CaMKII sites listed in [PhosphoSitePlus](http://www.phosphosite.org/substrateSearchViewAction.do?id=964&type=Protein) that have a D at +2 also have an Arg or Lys at −3, which is not the case for S286. This deserves discussion and raises the issue of whether CaMKII directly phosphorylates DAF-16 in vivo.

5\) Given the focus of the field to date on AKT regulation of FOXOs, the effect of the S286 phos status on the AKT site is very interesting. The submission goes some way to determining dominance between these two regulatory mechanisms ([Figure 7](#fig7){ref-type="fig"}), but it would benefit from going further in terms of the effects on aging. Does a S286A mutation or *unc-43* null inhibit the longevity effects of DAF-2 or AKT loss of function: i.e., is phos of S286 necessary for lifespan extension by FOXO, rather than sufficient?

6\) How does TAX-6/CNB-1 bind DAF-16 (i.e., what are the interaction domains in the two proteins?)?

7\) How does phosphorylation of S286 promote nuclear import of DAF-16 (e.g., does it reduce 14-3-3 binding?)?

10.7554/eLife.00518.029

Author response

*1) All the data presented related to phosphorylation/dephosphorylation have been produced through the use of expressed tagged constructs. None of the conclusions are supported by isolations of the endogenous proteins. Although the bulk of the claims based on biochemical analysis are well supported by genetic studies, direct evidence of interactions and covalent modification of endogenous proteins would strengthen the paper. It is suggested, but not required, that the authors consider using antibodies against the endogenous proteins to confirm their data*.

We agree with the reviewers wholeheartedly. We have tried from an early phase of this research to detect interactions and modifications of endogenous proteins. However, none of the antibodies we made (three for DAF-16, two for TAX-6, and two for UNC-43) are good enough for IP or WB of the endogenous proteins. We have a tiny bit of TAX-6 antiserum from Dr. Joohong Ahnn that can detect endogenous TAX-6, but it doesn't work for IP. Using this antibody we did not see endogenous TAX-6 in the DAF-16::GFP IP.

*2) The T240 site does not appear to be regulated, although again these relevant data are from expressed tagged proteins. There are no genetic studies for this site provided, which would strengthen the concept that this site is not involved*.

In the revised manuscript we provide genetic results further bolstering the conclusion that T240 is not phosphorylated by UNC-43. This is shown in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. If T240 phosphorylation mediates the effect of UNC-43, the T240A mutation should abolish DAF-16 nuclear accumulation. However, DAF-16(T240A) accumulated in the nucleus, even in an essentially WT background. This is consistent with T240 being an AKT phosphorylation site, not an UNC-43 phosphorylation site. The phenotype of DAF-16(T240A-S286A) is complex, but mostly mimicking a strong loss-of-AKT phenotype. This result again agrees with T240 being an AKT phosphorylation site and echoes with the other data shown in [Figure 8](#fig8){ref-type="fig"}, suggesting that insulin signaling overpowers UNC-43 signaling when in conflict. Lastly, DAF-16(T240A) has no effect on lifespan (below in Author response image 1), resembling DAF-16(4AM), in which four AKT consensus phosphorylation sites are all mutated to alanine ([@bib32] Nat. Gen. and Lee et al., 2001 Curr. Biol.).

*3) The conclusions of the paper would be substantively extended and the impact strengthened if the authors could provide evidence that this site of S286 of regulation of FOXO protein in mouse and human were operational. Good reagents are available for such studies, which would be easy to do in terms of both demonstrating phosphorylation/dephosphorylation as well as nuclear/cytoplasmic localization. In this regard, even though S286 is conserved in FOXO3, S303 in FOXO1, the equivalent of S299 in FOXO3, was not identified as a site whose phosphorylation was increased by CaMKIIg by Ozcan et al., and most of the reported sites were in Ser-Pro motifs, possibly phosphorylated as a result of p38 activation*.

We have added mammalian data ([Figure 9](#fig9){ref-type="fig"} and [Figure 10](#fig10){ref-type="fig"}) to the manuscript. Indeed, mammalian CAMKIIA and Calcineurin regulate FOXO3 phosphorylation at the same conserved site as DAF-16 S286, which is S298 in mouse FOXO3 (equivalent to S299 in human FOXO3). This regulation appears to be limited to FOXO3; phosphorylation of the equivalent site in FOXO1 by CAMKIIA was not detected. The FOXO1 results are summarized in the following paragraph, which is added to the paper under the section title "Mammalian CAMKII and Calcineurin also regulate phosphorylation of mouse FOXO3 at a conserved serine residue":

"A recent study by Ozcan et al. shows that four non-AKT phosphorylation sites are involved in the activation of murine FOXO1 by CAMKIIγ, likely through the p38 MAP kinase, in glucagon-stimulated hepatocytes ([@bib40]). Serine 300 of mouse FOXO1, the equivalent of S298 of mouse FOXO3, is not among them (S246, S295, S467, and S475). To find out whether the CAMKIIA isoform phosphorylates FOXO1 in the same way as it does FOXO3, we expressed a FLAG-tagged human FOXO1 in HEK293T cells co-transfected or not with CAMKIIA. Mass spec analysis identified three CAMKIIA-regulated phosphorylation sites equivalent to mouse FOXO1 S295, S467, and S475 (not shown). This agrees with the findings by Ozcan *et al*. and suggests that CAMKII directly phosphorylates FOXO3 but not FOXO1 in mammals."

*4) The sequence around DAF-16 S286(SIQTISHDLYD) is not that of a typical site for phosphorylation by CaMKII, which is a basophilic kinase, and is not predicted by Scansite to be a CaMKII site, even at low stringency, despite the authors' in vitro evidence that CaMKII can directly phosphorylate S286. All the mapped CaMKII sites listed in [PhosphoSitePlus](http://www.phosphosite.org/substrateSearchViewAction.do?id=964&type=Protein) that have a D at +2 also have an Arg or Lys at −3, which is not the case for S286. This deserves discussion and raises the issue of whether CaMKII directly phosphorylates DAF-16 in vivo*.

Indeed, DAF-16 S286 is not a typical CAMKII site. However, it has been reported that CAMKII can phosphorylate Ser or Thr residue within the sequence motif S/TXD (Yamauchi, 2005, Biol Pharm Bull.). DAF-16 S286 is found within such a motif, as is mFOXO3 S298 ([Figure 9A](#fig9){ref-type="fig"}). We found many examples among the mapped CAMKII sites from the PhosphoSite web page, where D at +2 is not accompanied by a K/R at -3. Below are some of them copied from [PhosphoSitePlus](http://www.phosphosite.org/substrateSearchViewAction.do?id=964&type=Protein) (Author response image 2):

*5) Given the focus of the field to date on AKT regulation of FOXOs, the effect of the S286 phos status on the AKT site is very interesting. The submission goes some way to determining dominance between these two regulatory mechanisms ([Figure 7](#fig7){ref-type="fig"}), but it would benefit from going further in terms of the effects on aging. Does a S286A mutation or* unc-43 *null inhibit the longevity effects of DAF-2 or AKT loss of function: i.e., is phos of S286 necessary for lifespan extension by FOXO, rather than sufficient*?

Yes, the relationship between insulin signaling and CAMKII signaling is very interesting. We found that *unc-43(null)* significantly shortened the lifespan of *daf-2(e1370)* by 31%, suggesting that UNC-43 transmits part of the signaling from DAF-2 ([Figure 7C](#fig7){ref-type="fig"}). However, the S286A mutation appeared to have no effect on lifespan extension by *daf-2* RNAi ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). We think that additional UNC-43 targets are involved in DAF-2 signaling.

*6) How does TAX-6/CNB-1 bind DAF-16 (i.e., what are the interaction domains in the two proteins?)*?

We performed pull-down assays with GST-tagged DAF-16 fragments and found that the C-terminal region of DAF-16 is important for TAX-6 binding. This is added as [Figure 1C](#fig1){ref-type="fig"}. The C-terminal region harbors the regulatory site S286.

*7) How does phosphorylation of S286 promote nuclear import of DAF-16 (e.g., does it reduce 14-3-3 binding?)*?

This is a very good question but unfortunately we are not able to answer it definitively. We found that *unc-43(gf)* increased phosphorylation at S286 and decreased phosphorylation at T240 on DAF-16 ([Figure 5D--E](#fig5){ref-type="fig"}), and this was indeed accompanied by a reduction of DAF-16-associated 14-3-3, as suspected by the reviewers ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). However, there are two possibilities for the negative correlation between S286 phosphorylation and T240 phosphorylation: AKT activity may be reduced in *unc-43(gf),* or phospho-S286 DAF-16 may be a poor substrate for AKT. Either would explain the reduction of T240 phosphorylation and 14-3-3 binding. If we had integrated strains of DAF-16(S286D)::6xHisGFP, we might have had a better chance to address this question by GFP IP and 14-3-3 WB, and finding out whether the S286D mutation reduces T240 phosphorylation. In any case, it remains to be determined whether S286 phosphorylation directly interferes with 14-3-3 binding or through reduced T240 phosphorylation.
